首页> 外文期刊>Acta Neurochirurgica >Long-term quality of life and tumour control following gamma knife radiosurgery for vestibular schwannoma
【24h】

Long-term quality of life and tumour control following gamma knife radiosurgery for vestibular schwannoma

机译:伽马刀放射治疗前庭神经鞘瘤后的长期生活质量和肿瘤控制

获取原文
获取原文并翻译 | 示例
           

摘要

Introduction: Gamma knife radiosurgery (GKRS) has for the last decades been an established treatment option for patients with small- or medium-sized vestibular schwannomas (VS), although little data is reported on long-term outcome regarding quality of life (QOL) and tumour control in this patient category. The objective of this study was to investigate long-term QOL and tumour control in GKRS-treated VS patients at our institution. Methods: Data was reviewed from a consecutive cohort of 128 patients, 62 men and 66 women, diagnosed with VS and treated with GKRS at Karolinska University Hospital between 1997 and 2003. Patients previously treated for VS, patients from abroad, and patients with neurofibromatosis were excluded from the study. Median age at the time of treatment was 66 years (range 23-89), with a median follow-up time of 104 months (range 11-165) and radiological median follow-up of 86 months (range 5-170). Five patients were lost to follow-up. Results: Data on QOL (EQ-5D score) was obtained in 90 % (98/109) of all cases at the end of follow-up, showing low morbidity and a high QOL with median index of 0.91 (max. score 1.0) in these patients. Tumour control was achieved in 92 % (118/128) of patients after a single GKRS treatment. Ten patients had loss of tumour control, either radiologically seen as growth progression, or due to the need for salvage treatment. Neither pre-treatment growth of the vestibular schwannoma, or a large tumour size (Koos grade 3 & 4) was correlated with a higher degree of treatment failure (p = 0.695 and p = 0.647, respectively). There was no difference in tumour control in young (<60 y/o) vs. elderly (≥60 y/o) patients (p = 0.167). Conclusion: We report a high QOL and low morbidity at long-term follow-up after GKRS treatment in VS patients. Furthermore, a high tumour control rate was achieved independent of tumour size, patient age or pre-treatment evidence of tumour growth.
机译:简介:在过去的几十年中,伽玛刀放射外科(GKRS)已成为中小前庭神经鞘瘤(VS)患者的既定治疗选择,尽管有关生活质量(QOL)的长期结果的报道很少和该患者类别的肿瘤控制。这项研究的目的是调查我们机构中接受GKRS治疗的VS患者的长期QOL和肿瘤控制。方法:回顾性分析了1997年至2003年间在K​​arolinska大学医院接受VS诊断并接受GKRS治疗的128例患者(62例男性和66例女性)的队列研究。以前接受过VS治疗的患者,国外患者和神经纤维瘤患者从研究中排除。治疗时的中位年龄为66岁(范围23-89),中位随访时间为104个月(范围11-165),放射学中位随访为86个月(范围5-170)。五名患者失去随访。结果:随访结束时,所有病例中有90%(98/109)获得了QOL(EQ-5D评分)数据,显示发病率低且QOL高,中位指数为0.91(最大评分1.0)。在这些患者中。单一GKRS治疗后92%(118/128)的患者达到了肿瘤控制。十名患者失去了肿瘤控制能力,无论是放射学上看为生长进展,还是由于需要抢救治疗。前庭神经鞘瘤的治疗前生长或大肿瘤(Koos 3和4级)均与较高的治疗失败率无关(分别为p = 0.695和p = 0.647)。年轻患者(<60岁)与老年患者(≥60岁)的肿瘤控制无差异(p = 0.167)。结论:我们报告VS患者GKRS治疗后长期随访发现其高QOL和低发病率。此外,获得了高肿瘤控制率,与肿瘤大小,患者年龄或肿瘤生长的治疗前证据无关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号